HM13 and pneumocystosis: Significantly more patients with SAP were taking PCP prophylaxis (55% for SAP vs. 22% for SPP, p<0.001) and specifically taking trimethoprim- sulfamethoxazole, TMP-SMX (33% for SAP vs. 15% for SPP, p=0.02).